Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Frontage Holdings Corp. ( (HK:1521) ) is now available.
Frontage Holdings Corporation announced a change in its executive team with the resignation of Mr. Jun (Henry) Gao as Chief Financial Officer, effective July 15, 2025, due to his pursuit of other professional endeavors. Ms. Huan Wang, with extensive experience in the pharmaceutical and CRO industry, will assume the role of interim CFO. This transition is expected to maintain the company’s financial stability and strategic direction, given Ms. Wang’s long-standing involvement with the company and her role in its financial operations.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
More about Frontage Holdings Corp.
Frontage Holdings Corporation operates in the pharmaceutical and contract research organization (CRO) industry, providing services such as accounting, budgeting, and financial operations. The company focuses on financial planning, analysis, internal controls, and financial reporting, with a history of participating in significant financial events like initial public offerings.
Average Trading Volume: 270,482
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$2.24B
For an in-depth examination of 1521 stock, go to TipRanks’ Overview page.